Register entry
Lonza Biologics Tuas Pte. Ltd.
- Registered sites
- 0
- Drug products
- 11
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Adalimumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Adalimumab, Citrate Free | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | EFGARTIGIMOD ALFA | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Eculizumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Lebrikizumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Trastuzumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | dornase alfa | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | efgartigimod SC | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | infliximab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | luspatercept | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | narsoplimab | LIQUID | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.